TCI使用Cookie來個(gè)性化和改善您的用戶體驗(yàn),您可以訪問我們的隱私權(quán)政策 了解更多信息。
Maximum quantity allowed is 999
請(qǐng)選擇數(shù)量
CAS RN: 190791-29-8 | 產(chǎn)品編碼: L0336
Lasofoxifene Tartrate

純度/分析方法: >98.0%(HPLC)
別名:
- 酒石酸拉索昔芬
- (5R,6S)-5,6,7,8-四氫-6-苯基-5-[4-[2-(1-吡咯烷基)乙氧基]苯基]-2-萘酚酒石酸鹽
- (5R,6S)-5,6,7,8-Tetrahydro-6-phenyl-5-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]-2-naphthalenol Tartrate
- Oporia
產(chǎn)品文檔:
* 點(diǎn)擊“查詢”可查看預(yù)計(jì)發(fā)貨日期,僅供參考。
* 無具體發(fā)貨日期的情況,如:顯示“8個(gè)工作日后發(fā)貨”,將在您訂購日起的8個(gè)工作日后發(fā)貨。
* 我們將以最優(yōu)方式從上海/天津兩大倉庫發(fā)貨。國內(nèi)庫存不足,需兩周左右向日本總部調(diào)貨。
* 對(duì)于可分裝產(chǎn)品,11:30前的訂單,當(dāng)天發(fā)貨;11:30后的訂單,隔天發(fā)貨。
* 如需大包裝,請(qǐng)點(diǎn)擊“大包裝詢價(jià)”按鈕(對(duì)于某些產(chǎn)品我們無法提供大包裝)。
* TCI會(huì)經(jīng)常復(fù)審儲(chǔ)藏條件以對(duì)其進(jìn)行優(yōu)化,請(qǐng)以在線目錄為準(zhǔn),敬請(qǐng)留意。
* 更多信息,請(qǐng)聯(lián)系營業(yè)部:021-67121386 / Sales-CN@TCIchemicals.com 。任何貨期、規(guī)格或包裝方面的需求,請(qǐng)聯(lián)系我們 。
* 無具體發(fā)貨日期的情況,如:顯示“8個(gè)工作日后發(fā)貨”,將在您訂購日起的8個(gè)工作日后發(fā)貨。
* 我們將以最優(yōu)方式從上海/天津兩大倉庫發(fā)貨。國內(nèi)庫存不足,需兩周左右向日本總部調(diào)貨。
* 對(duì)于可分裝產(chǎn)品,11:30前的訂單,當(dāng)天發(fā)貨;11:30后的訂單,隔天發(fā)貨。
* 如需大包裝,請(qǐng)點(diǎn)擊“大包裝詢價(jià)”按鈕(對(duì)于某些產(chǎn)品我們無法提供大包裝)。
* TCI會(huì)經(jīng)常復(fù)審儲(chǔ)藏條件以對(duì)其進(jìn)行優(yōu)化,請(qǐng)以在線目錄為準(zhǔn),敬請(qǐng)留意。
* 更多信息,請(qǐng)聯(lián)系營業(yè)部:021-67121386 / Sales-CN@TCIchemicals.com 。任何貨期、規(guī)格或包裝方面的需求,請(qǐng)聯(lián)系我們 。
技術(shù)規(guī)格
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
NMR | confirm to structure |
物性(參考值)
熔點(diǎn) | 185 °C(dec.) |
GHS
相關(guān)法規(guī)
RTECS# | QK4252964 |
新化學(xué)物質(zhì)備案回執(zhí)號(hào) | B1A232214963 |
運(yùn)輸信息
監(jiān)管條件代碼(*) |
應(yīng)用
Lasofoxifene tartrate: A Third-Generation, Non-Steroidal Selective Estrogen Receptor Modulator (SERM)
Lasofoxifene tartrate (CP-336156) is a third-generation, non-steroidal selective estrogen receptor modulator (SERM). SERMs have the ability to provide mixed functional estrogen receptor (ER) agonist or antagonist activity, depending on the target tissue. Lasofoxifene has a remarkably improved oral bioavailability with respect to other SERMs, selectively binds to both ERα and ERβ with high affinity, and acts as a tissue selective estrogen antagonist or agonist.1-3) It has been reported that lasofoxifene prevents estrogen deficiency-induced bone loss, inhibits breast tumor formation and reduces serum cholesterol. In clinical, lasofoxifene tartrate has been used for the treatment of osteoporosis4) and breast cancer.5,6) (The product is for research purpose only.)
References
- 1) Effects of CP-336,156, a new, nonsteroidal estrogen agonist/antagonist, on bone, serum cholesterol, uterus, and body composition in rat models
- 2) Discovery and Preclinical Pharmacology of a Novel, Potent, Nonsteroidal Estrogen Receptor Agonist/Antagonist, CP-336156, a Diaryltetrahydronaphthalene
- 3) Lasofoxifene (CP-336,156), a selective estrogen receptor modulator, prevents bone loss induced by aging and orchidectomy in the adult rat
- 4) Lasofoxifene: a third-generation selective estrogen receptor modulator for the prevention and treatment of osteoporosis (a review)
- 5) Preventive therapy for breast cancer: a consensus statement (a review)
- 6) The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice (a review)
產(chǎn)品文檔 (部分產(chǎn)品的分析圖譜無法提供,敬請(qǐng)諒解。)
化學(xué)品安全說明書(SDS)
請(qǐng)選擇語言。
如需更多幫助,請(qǐng)聯(lián)系我 們。
技術(shù)規(guī)格
CoA及其他文檔
請(qǐng)輸入批號(hào)
批號(hào)輸入有誤。請(qǐng)輸入中橫線前的4-5個(gè)字母數(shù)字字符。
示例 CoA
可下載CoA示例。注:該示例不一定是最新批次的CoA。
目前沒有該產(chǎn)品的 CoA?示例。
分析圖譜
請(qǐng)輸入批號(hào)
批號(hào)輸入有誤。請(qǐng)輸入中橫線前的4-5個(gè)字母數(shù)字字符。
很抱歉,您搜索的分析圖譜無法提供。